Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction.

@article{Heidenreich2004CosteffectivenessOS,
  title={Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction.},
  author={Paul A. Heidenreich and Matthew A. Gubens and Gregg C Fonarow and Marvin A. Konstam and Lynne Warner Stevenson and Paul G. Shekelle},
  journal={Journal of the American College of Cardiology},
  year={2004},
  volume={43 6},
  pages={1019-26}
}
OBJECTIVES This study was designed to evaluate the cost-effectiveness of screening patients with a B-type natriuretic peptide (BNP) blood test to identify those with depressed left ventricular systolic function. BACKGROUND Asymptomatic patients with depressed ejection fraction (EF) may have less progression to heart failure if they can be identified and treated. METHODS We used a decision model to estimate economic and health outcomes for different screening strategies using BNP and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 61 extracted citations

Similar Papers

Loading similar papers…